Skip to content

Effect of endoscopic treatments of Barrett's oesophagus on oesophageal motility and reflux

Effect of endoscopic treatments of Barrett's oesophagus on oesophageal motility and reflux - Motility and reflux after endoscopic treatment Barrett

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30256
Enrollment
20
Registered
2006-12-18
Start date
2007-02-26
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oesophageal motility reflux

Interventions

None listed

Sponsors

St. Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Barrett's oesophagus with high-grade dysplasia Scheduled for endoscopic treatment with SRER or BARRx

Exclusion criteria

Exclusion criteria: Prior surgery of the stomach or oesophagus condition with contraindicates the cessation of PPI therapy such as peptic ulcer disease

Design outcomes

Primary

MeasureTime frame
Using oesophageal manometry the following parameters will be assessed: % of contractions that are peristaltic, contraction amplitude and duration in the proximal and distal oesophagus, lower oesophageal sphincter pressure and relaxation nadir pressure. Impedance-pH measurements will be analyzed for number and type (acid, weakly acidic, liquid, gas or mixed liquid-gas reflux) of reflux episodes and proximal extent of the reflux episodes. In addition, % of time with oesophageal pH

Secondary

MeasureTime frame
-

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)